Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade-Reference-Cited by-同舟云学术

Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade

Published:2024-02-07 Issue: Volume: Page:
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yu Yongkang¹²^ORCID,Zhang Fan¹,Xiao Wenqing¹,Cheng Qinzhen²,Li Tingxuan¹,Tang Jing²,Tao Wei³^ORCID,Mei Lin¹^ORCID

Affiliation:

1. State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, PR China

2. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, PR China

3. Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Funder

Science Fund for Distinguished Young Scholars of Tianjin Municipality

National Natural Science Foundation of China

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

the Fundamental Research Funds for the Central Universities

Science and Technology Program of Tianjin City

the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c13056

Reference53 articles.